BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Down 99.2% in July

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the target of a large drop in short interest in the month of July. As of July 31st, there was short interest totaling 1,000 shares, a drop of 99.2% from the July 15th total of 132,765 shares. Based on an average daily volume of 484 shares, the days-to-cover ratio is currently 2.1 days. Currently, 0.0% of the company’s shares are sold short.

BioNxt Solutions Price Performance

Shares of BNXTF opened at $0.23 on Wednesday. BioNxt Solutions has a one year low of $0.14 and a one year high of $0.80. The company has a 50-day moving average of $0.24 and a two-hundred day moving average of $0.34. The stock has a market cap of $31.87 million, a price-to-earnings ratio of -4.68 and a beta of 0.70.

BioNxt Solutions (OTCMKTS:BNXTF) last released its quarterly earnings results on Friday, May 29th. The company reported ($0.01) earnings per share (EPS) for the quarter.

About BioNxt Solutions

BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.

BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.